⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30807948 | 0.97 | — | — | |
| SCHEMBL2670377 | 0.71 | — | — | |
| SCHEMBL3065604 | 0.63 | — | — | |
| SCHEMBL2554291 | 0.47 | — | — | |
| SCHEMBL622521 | 0.45 | — | — | |
| SCHEMBL452580 | 0.40 | — | — | |
| SCHEMBL2138977 | 0.40 | — | — | |
| SCHEMBL56545 | 0.36 | — | — | |
| SCHEMBL2326 | 0.36 | — | — | |
| SCHEMBL34570 | 0.36 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 808 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240374590-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER | COILED THERAPEUTICS, INC. | 2024-11-14 | — | — | US | claimed |
| US-20240322218-A1 | DIAMONDOID SALTS AND RELATED COMPOSITIONS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2024-09-26 | — | — | US | claimed |
| EP-4412991-A1 | DERIVATIVES OF ARYL HYDROCARBON RECEPTOR AGONISTS | AZORA THERAPEUTICS, INC. (US) | 2024-08-14 | — | — | EP | claimed |
| US-20240217979-A1 | GluN2 Subunit Selective Antagonists of the N-Methyl-D-Aspartate Receptors | UNIV EMORY (US) | 2024-07-04 | — | — | US | claimed |
| EP-4371180-A1 | DIAMONDOID SALTS AND RELATED COMPOSITIONS | Wisconsin Alumni Research Foundation (US) | 2024-05-22 | — | — | EP | claimed |
| EP-4323351-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER | A2A Pharmaceuticals, Inc. (US) | 2024-02-21 | — | — | EP | claimed |
| WO-2023060268-A1 | DERIVATIVES OF ARYL HYDROCARBON RECEPTOR AGONISTS | AZORA THERAPEUTICS, INC. (US) | 2023-04-13 | — | — | WO | claimed |
| EP-4159213-A1 | PHARMACEUTICAL COMPOSITIONS FOR USE IN PREVENTION AND/OR TREATMENT AND/OR CURE OF HEPATITIS B VIRUS | Katholieke Universiteit Leuven (BE) | 2023-04-05 | — | — | EP | claimed |
| WO-2023288193-A1 | DIAMONDOID SALTS AND RELATED COMPOSITIONS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2023-01-19 | — | — | WO | claimed |
| WO-2022226161-A1 | GLUN2 SUBUNIT SELECTIVE ANTAGONISTS OF THE N-METHYL-D-ASPARTATE RECEPTORS | EMORY UNIVERSITY (US) | 2022-10-27 | — | — | WO | claimed |
| US-20070004709-A1 | Thiadiazine derivatives and use thereof as positive ampa receptor modulators | THE UNIVERSITE DE LIEGE (BE) | 2007-01-04 | — | — | US | claimed |
| EP-1385823-B1 | GUANIDINO COMPOUNDS AS MELANOCORTIN-4 RECEPTOR (MC4-R) AGONISTS | CHIRON CORP (US) | 2006-12-13 | — | — | EP | claimed |
| WO-2006124687-A1 | OPIOID RECEPTOR SUBTYPE-SELECTIVE AGENTS | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2006-11-23 | — | — | WO | claimed |
| EP-1526895-A2 | METHODS FOR TREATING CARBONIC ANHYDRASE MEDIATED DISORDERS | Pharmacia Corporation (US) | 2005-05-04 | — | — | EP | claimed |
| WO-2004014352-A2 | METHODS FOR TREATING CARBONIC ANHYDRASE MEDIATED DISORDERS | PHARMACIA CORPORATION (US) | 2004-02-19 | — | — | WO | claimed |
| US-20030220376-A1 | Methods for treating carbonic anhydrase mediated disorders | PHARMACIA CORPORATION | 2003-11-27 | — | — | US | claimed |
| WO-2003047571-A2 | USE OF A KMO INHIBITOR FOR PRODUCING A PHARMACEUTICAL COMPOSITION | METAGEN PHARMACEUTICALS GMBH (DE) | 2003-06-12 | — | — | WO | claimed |
| WO-1995020637-A2 | HYDROCARBON OIL-AQUEOUS FUEL AND ADDITIVE COMPOSITIONS | MEG S.N.C. DI SCOPELLITI SOFIA & C. (IT) | 1995-08-03 | — | — | WO | claimed |
| US-5098806-A | Photochromic film filter turning opaque prior to copier's light; reverts to transparent | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1992-03-24 | — | — | US | claimed |
| EP-0428339-A2 | Heterocyclic compounds | ZENECA LIMITED (GB) | 1991-05-22 | — | — | EP | claimed |